FLENX
Price
$51.92
Change
-$0.35 (-0.67%)
Updated
Aug 10 closing price
Net Assets
4.04B
VSTSX
Price
$365.81
Change
-$0.25 (-0.07%)
Updated
Aug 10 closing price
Net Assets
2.29T
Interact to see
Advertisement

FLENX vs VSTSX

FLENX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
FLENX vs. VSTSX commentary
Aug 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLENX is a StrongBuy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.29T vs. FLENX (4.04B). VSTSX pays higher dividends than FLENX: VSTSX (1.08) vs FLENX (0.00). FLENX was incepted earlier than VSTSX: FLENX (2 years) vs VSTSX (10 years). FLENX (0.73) is less costly to investors than VSTSX (0.01). FLENX is a more actively managed with annual turnover of: 12.00 vs. VSTSX (3.00). FLENX has a lower initial minimum investment than VSTSX: FLENX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 22.12 vs. FLENX (17.83). VSTSX return over 5 years is better than : 67.37 vs. FLENX (19.06).
FLENXVSTSXFLENX / VSTSX
Total Expense Ratio0.730.017,300%
Annual Report Gross Expense Ratio0.730.017,300%
Fund Existence2 years10 years-
Gain YTD19.20213.947138%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.04B2.29T0%
Annual Yield % from dividends0.001.08-
Returns for 1 year17.8322.1281%
Returns for 3 years52.9572.7373%
Returns for 5 years19.0667.3728%
Returns for 10 years26.12243.4011%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMPCX34.840.09
+0.26%
American Funds AMCAP C
GGCAX134.50N/A
N/A
Gabelli Growth A
TRWFX29.89N/A
N/A
Transamerica International Equity R4
ABICX21.30N/A
N/A
AB International Value C
RSQCX16.38-0.15
-0.91%
Royce Small-Cap Special Equity Consult